|
paromomycin biosynthetic process
|
GO_1901155 |
[The chemical reactions and pathways resulting in the formation of paromomycin.] |
|
obsolete neomycin metabolic process
|
GO_1901156 |
[OBSOLETE. The chemical reactions and pathways involving neomycin.] |
|
neomycin catabolic process
|
GO_1901157 |
[The chemical reactions and pathways resulting in the breakdown of neomycin.] |
|
neomycin biosynthetic process
|
GO_1901158 |
[The chemical reactions and pathways resulting in the formation of neomycin.] |
|
intermediate mesoderm morphogenesis
|
GO_0048390 |
[The process in which the anatomical structures of the intermediate mesoderm are generated and organized.] |
|
D-xylulose 5-phosphate biosynthetic process
|
GO_1901159 |
[The chemical reactions and pathways resulting in the formation of D-xylulose 5-phosphate.] |
|
endosomal lumen acidification
|
GO_0048388 |
[Any process that reduces the pH of the endosomal lumen, measured by the concentration of the hydrogen ion.] |
|
intracellular pH reduction
|
GO_0051452 |
[Any process that reduces the internal pH of a cell, measured by the concentration of the hydrogen ion.] |
|
intermediate mesoderm development
|
GO_0048389 |
[The process whose specific outcome is the progression of the intermediate mesoderm over time, from its formation to the mature structure. The intermediate mesoderm is located between the lateral mesoderm and the paraxial mesoderm. It develops into the kidney and gonads.] |
|
mesendoderm development
|
GO_0048382 |
[The process whose specific outcome is the progression of the mesendoderm over time, from its formation to the mature structure. In animal embryos, mesendoderm development gives rise to both mesoderm and endoderm tissues.] |
|
mesectoderm development
|
GO_0048383 |
[The process whose specific outcome is the progression of the mesectoderm over time, from its formation to the mature structure. In animal embryos, mesectoderm development processes give rise to both mesoderm and ectoderm tissues.] |
|
negative regulation of lateral mesodermal cell fate specification
|
GO_0048380 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of lateral mesoderm cell fate specification.] |
|
lateral mesoderm structural organization
|
GO_0048381 |
[The process that contributes to the act of creating the structural organization of the lateral mesoderm. This process pertains to the physical shaping of a rudimentary structure.] |
|
obsolete primary amino compound metabolic process
|
GO_1901160 |
[OBSOLETE. The chemical reactions and pathways involving primary amino compound.] |
|
positive regulation of retinoic acid receptor signaling pathway
|
GO_0048386 |
[Any process that activates or increases the frequency, rate or extent of retinoic acid receptor signaling pathway activity.] |
|
regulation of retinoic acid receptor signaling pathway
|
GO_0048385 |
[Any process that modulates the frequency, rate or extent of retinoic acid receptor signaling pathway activity.] |
|
negative regulation of retinoic acid receptor signaling pathway
|
GO_0048387 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of retinoic acid receptor signaling pathway activity.] |
|
primary amino compound biosynthetic process
|
GO_1901162 |
[The chemical reactions and pathways resulting in the formation of primary amino compound.] |
|
retinoic acid receptor signaling pathway
|
GO_0048384 |
[A nuclear receptor-mediated signaling pathway initiated by a retinoic acid binding to an intracellular receptor of the nuclear receptor protein family, and ending with regulation of a downstream cellular process, e.g. transcription.] |
|
nuclear receptor-mediated signaling pathway
|
GO_0141193 |
[The series of molecular signals initiated by a signaling molecule binding to an intracellular receptor of the nuclear receptor protein family, and ending with regulation of a downstream cellular process, e.g. transcription.] |